Aix-Marseille Univ, IRD, APHM, MEPHI, IHU Méditerranée Infection, Marseille, France.
Aix-Marseille Univ, APHM, Hôpital Nord, Marseille, France.
Allergy. 2019 Jun;74(6):1157-1165. doi: 10.1111/all.13752. Epub 2019 Mar 21.
Anaphylaxis is recognized mainly through clinical criteria, which may lack specificity or relevance in the perioperative setting. The transient increase in serum tryptase has been proposed since 1989 as a diagnostic tool. Sampling for well-defined acute and baseline determinations has been recommended. We assessed the performance of four proposed algorithms with tightly controlled time frames for tryptase sampling, their robustness with inadequate sampling times, and the possible use of mature tryptase determination.
A retrospective study was performed on 102 adult patients from the Aix-Marseille University Hospitals who had experienced a perioperative hypersensitivity reaction clinically suggesting anaphylaxis. EAACI and ICON criteria were used to diagnose anaphylaxis. Mature and total serum tryptase levels were measured.
Based on EAACI guidelines, clinical diagnostic criteria for anaphylaxis were found in 76 patients and lacking in 26. The most effective algorithm was the international consensus recommendation of 2012 that acute total tryptase levels should be greater than ([1.2×baseline tryptase] + 2] μg/L to be considered a clinically significant rise. In our cohort, this algorithm achieved 94% positive predictive value (PPV), 53% negative predictive value (NPV), 75% sensitivity, 86% specificity, and a Youden's index value of 0.61. A detectable acute mature tryptase level showed lower sensitivity, particularly in patients with acute total tryptase levels lower than 16 μg/L. Acute tryptase levels varied as a function of the clinical severity of anaphylaxis.
Total tryptase levels in serum discriminated between nonanaphylactic and anaphylactic events in a perioperative setting when acute and baseline levels were collected and analyzed by the consensus algorithm.
过敏反应主要通过临床标准来识别,但在围手术期,这些标准可能缺乏特异性或相关性。自 1989 年以来,血清类胰蛋白酶的短暂增加已被提议作为一种诊断工具。建议进行明确的急性和基线测定采样。我们评估了四个建议的算法的性能,这些算法在类胰蛋白酶采样时具有严格控制的时间框架,评估了它们在采样时间不足时的稳健性,以及成熟的类胰蛋白酶测定的可能用途。
对来自艾克斯马赛大学医院的 102 名经历过围手术期过敏反应的成年患者进行了回顾性研究,这些反应临床上提示过敏反应。使用 EAACI 和 ICON 标准诊断过敏反应。测量成熟和总血清类胰蛋白酶水平。
根据 EAACI 指南,76 例患者存在过敏反应的临床诊断标准,26 例患者缺乏。最有效的算法是 2012 年国际共识建议,即急性总类胰蛋白酶水平应大于([1.2×基线类胰蛋白酶]+2]μg/L 被认为是临床上显著升高。在我们的队列中,该算法的阳性预测值(PPV)为 94%,阴性预测值(NPV)为 53%,敏感性为 75%,特异性为 86%,约登指数值为 0.61。可检测到的急性成熟类胰蛋白酶水平的敏感性较低,尤其是在急性总类胰蛋白酶水平低于 16μg/L 的患者中。急性类胰蛋白酶水平随过敏反应的临床严重程度而变化。
在围手术期,当通过共识算法收集和分析急性和基线水平时,血清总类胰蛋白酶水平可区分非过敏反应和过敏反应事件。